Have the presented results of GOG 249 at ASTRO 2017 changed management of early stage uterine papillary serous cancers from chemo +VC/EBRT to pelvic RT only?

UPSC tend to fail with distant mets. Therefore chemotherapy is reasonable.

Per the study results Chemo + VC/EBRT is reasonable.

At times chemo is not feasible/ tolerated so we use EBRT+ Vc.

I have enrolled pts on this study and noted the interesting results.